Business News/Market/Market Stats/   Concord Biotech share price
Mutual Fund Ownership
Ownership as on: Tue, 26 Sep, 2023

DSP Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)60.83
% of AUM3.70%

Baroda BNP Paribas Large and Mid Cap Fund Regular Growth

NA
Other
Amount Invested (Cr.)18.65
% of AUM2.24%

UTI Healthcare Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)15.05
% of AUM1.94%

Edelweiss Recently Listed IPO Fund Regular Plan Growth

NA
Equity
Amount Invested (Cr.)17.87
% of AUM1.87%

Mirae Asset Healthcare Fund Regular Growth

NA
Equity
Amount Invested (Cr.)29.81
% of AUM1.64%

Concord Biotech SUMMARY

Concord Biotech is trading 0.73% upper at Rs 999.25 as compared to its last closing price. Concord Biotech has been trading in the price range of 1006.55 & 991.60.

 

The company posted a net profit of 54.49 Crores in its last quarter.

 

Listed peers of Concord Biotech include Mankind Pharma (0.50%), Concord Biotech (0.73%), TVS Supply Chain Solutions (-0.12%) etc.

FAQs about Concord Biotech share price

Concord Biotech is trading at 999.25 as on Tue Sep 26 2023 09:59:45. This is 0.73% upper as compared to its previous closing price of 992.05.

The market capitalization of Concord Biotech is 10453.77 Cr as on Tue Sep 26 2023 09:59:45.

The 52 wk high for Concord Biotech is 1067.50 whereas the 52 wk low is 900.00

Concord Biotech can be analyzed on the following key metrics -

  • TTM P/E: -
  • Sector P/E: 20.68
  • Dividend Yield: 0.00%
  • D/E ratio: -

Concord Biotech reported a net profit of 240.09 Cr in 2023.

Recommended For You
Trending Stocks
22972.70+327.45(1.45%)
128.85+1.50(1.18%)
1282.10-16.90 (-1.30%)
1423.50-18.55 (-1.29%)